Concerns about health care warnings and their impact on prescribing behaviour
- 17 July 2008
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 179 (5) , 405-406
- https://doi.org/10.1503/cmaj.080901
Abstract
In this issue of CMAJ Valiyeva and colleagues[1][1] report on the impact of 3 regulatory warnings on prescription rates of antipsychotic drugs among elderly adults with dementia. Their finding — that the warnings did not achieve the desired outcome — is similar to that in a recent study on theKeywords
This publication has 11 references indexed in Scilit:
- Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysisCMAJ : Canadian Medical Association Journal, 2008
- Health advisories: when good intentions go badCMAJ : Canadian Medical Association Journal, 2008
- Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adultsCMAJ : Canadian Medical Association Journal, 2008
- Antipsychotic Drug Use and Mortality in Older Adults with DementiaAnnals of Internal Medicine, 2007
- Use of Nesiritide Before and After Publications Suggesting Drug-Related Risks in Patients With Acute Decompensated Heart FailureJAMA, 2006
- Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's DiseaseNew England Journal of Medicine, 2006
- Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic MedicationsNew England Journal of Medicine, 2005
- Risk of Death With Atypical Antipsychotic Drug Treatment for DementiaJAMA, 2005
- The impact of wording in “Dear doctor” letters and in black box labelsClinical Pharmacology & Therapeutics, 2002
- Contraindicated Use of CisaprideJAMA, 2000